Hemgenix has long been offered ‘conditional authorisation’. Because of this the European Medicines Agency made a decision that the advantages of Hemgenix are larger than its risks, but the corporation must provide added evidence soon after authorisation. As for all medicines, data on the use of Hemgenix are constantly monitored. https://hemgenix38263.thelateblog.com/36463481/about-hemgenix